tiprankstipranks

Novavax asked for new Covid-19 vaccine trial by FDA, WSJ reports

Federal regulators have asked Novavax (NVAX) to conduct another randomized clinical trial of its Covid-19 vaccine following earlier delays in approval, Liz Essley Whyte of The Wall Street Journal reported, citing people familiar with the matter. This request reportedly could be so costly it threatens the company’s ability to comply. The company was asked by the FDA to show its vaccine is effective with another randomized study after appointees under Health Secretary Robert F. Kennedy Jr. intervened, the people said.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue